Radioembolization of Yttrium-90 Microspheres for Clinical Treatment of Hepatic MalignancySahar Alee Koloukani1, Ailin Cao2 and Qi Cao1*
- *Corresponding Author:
- Qi Cao
Department of Diagnostic radiology and Nuclear Medicine
University of Maryland School of Medicine
22 South Greene Street
Baltimore, Maryland 21201, USA
Tel: 410 -328-9586
E-mail: [email protected]
Received date: June 06, 2014; Accepted date: July 29, 2014,; Published date: July 31, 2014
Citation: Koloukani SA, Cao A, Cao Q (2014) Radioembolization of Yttrium-90 Microspheres for Clinical Treatment of Hepatic Malignancy. J Nucl Med Radiat Ther 5:187. doi: 10.4172/2155-9619.1000187
Copyright: © 2014 Koloukani SA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Trans hepatic arterial radioembolotherapy using yttrium-90 microspheres represents in situ therapy in hepatocellular cancer, which is the third leading cause of cancer-related deaths in the world. This therapy shows interesting results in the treatment of these patients. This review focuses on clinical application, advantages, sideeffects and toxicity, and contradictions of the radioembolization treatment program.